Page last updated: 2024-11-05

methylethylnitrosamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID25418
CHEMBL ID164852
CHEBI ID82360
MeSH IDM0068314

Synonyms (57)

Synonym
ethanamine,n-methyl-n-nitroso-
n-methyl-n-nitrosoethanamine
nitrosoethylmethylamine
10595-95-6
ethylmethylnitrosamine
methylethylnitrosoamine
methylaethylnitrosamin [german]
brn 1742021
ccris 3058
methylethylnitrosamine
n-ethyl-n-methylnitrosamine
n-nitrosomethylethylamine
n,n-methylethylnitrosamine
n-methyl-n-nitrosoethylamine
hsdb 5109
n-nitrosoethylmethylamine
ethylamine, n-methyl-n-nitroso-
ethanamine, n-methyl-n-nitroso-
n-nitroso-n-methylethylamine
ethylnitrosomethylamine
nitrosomethylethylamine
inchi=1/c3h8n2o/c1-3-5(2)4-6/h3h2,1-2h3
rtdcjkarqcronf-uhfffaoysa-
CHEMBL164852
chebi:82360 ,
n-ethyl-n-methylnitrous amide
NCGC00248817-01
AKOS006283561
C19281
00rlm29y3a ,
unii-00rlm29y3a
methylaethylnitrosamin
tox21_200744
cas-10595-95-6
dtxsid6021036 ,
NCGC00258298-01
dtxcid401036
n-ethyl-n-methyl-nitrous amide
FT-0672957
ethyl-n-methylnitrosamine, n-
n-nitrosomethylethylamine [iarc]
n-nitrosomethylethylamine [hsdb]
n-methyl-n-nitroso-ethamine
RTDCJKARQCRONF-UHFFFAOYSA-N
1-ethyl-1-methyl-2-oxohydrazine #
J-001510
n-nitroso-methyl-ethylamine 100 microg/ml in methanol
n-nitroso-methyl-ethylamine
n-ethyl-n-methyl-n-nitrosoamine
n-nitrosomethylethylamine (nmea)
n-nitroso-methylethylamine
ethyl(methyl)nitrosoamine
Q27155899
ethanamine, n-methyl-n-nitroso
n-nitroso-methyl-ethylamine 1000 microg/ml in methanol
EN300-208578
Z1198147516

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Larger doses given by gavage indicated a systemic bioavailability of 25 +/- 1%."( Single-dose toxicokinetics of N-nitrosomethylethylamine and N-nitrosomethyl (2,2,2-trideuterioethyl)amine in the rat.
Anderson, LM; Heur, YH; Keefer, LK; Kleihues, P; Mico, BA; Nelson, VC; Nims, RW; Streeter, AJ; von Hofe, E, 1990
)
0.28

Dosage Studied

ExcerptRelevanceReference
" The AEM converted anions in the eluent to hydroxide ions after HPLC separation and increased eluent pH, allowing for the subsequent photochemical reactions, which are otherwise achieved by pH conditioning with an additional dosing pump of basic chemical."( An inline ion-exchange system in a chemiluminescence-based analyzer for direct analysis of N-nitrosamines in treated wastewater.
Fujioka, T; Ishida, KP; Kodamatani, H; Maruyama, N; Masunaga, H; Plumlee, MH; Roback, SL, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
nitroso compoundCompounds having the nitroso group, -NO, attached to carbon, or to another element, most commonly nitrogen or oxygen.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.00380.006038.004119,952.5996AID1159521
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID226732The compound was modelled in silico for carcinogenic potency; + = Carcinogen1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Computer-assisted studies of structure-activity relationships of N-nitroso compounds using pattern recognition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (43.33)18.7374
1990's4 (13.33)18.2507
2000's2 (6.67)29.6817
2010's8 (26.67)24.3611
2020's3 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.69 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index5.12 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (96.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]